Publication: Eliciting health state utilities for aromatic L-amino acid decarboxylase (AADC) deficiency: A vignette study in France
This research article, published in Journal of Patient-Reported Outcome Measures, presents an approach specific to France that evaluates the impact of AADC deficiency on health-related quality of life
- Learn about the development of France-specific health-state utilities for AADC deficiency
- Understand how hypothetical health-state vignettes, developed using participants who imagine themselves as the parent or caregiver of a child with AADC deficiency, were used to develop health-state utilities
- Recognize the potential importance of these health-state utilities in economic modelling to investigate the cost-effectiveness of AADC deficiency treatment
Smith AB, et al. Patient Relat Outcome Meas. 2021;12 237–246
Thank you!
Already registered?
Register now to access the content on this page
Already registered?
If not, register below
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
MED-ALL-CORP-2200029 | June 2025
COMING SOON
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.